Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.

The article describes the case study for determining if probiotic Lactobacillus reuteri DSM 17938 reduce crying or fussing in infants aged less than 3 months with colic. The case study performed a double blind, placebo controlled randomised trial of Lactobacillus reuteri DSM 17938, wherein randomisation was stratified by using block randomisation and computer generated allocation. It is determined that Lactobacillus reuteri treatment did not reduce crying of fussing in infants with colic.